Predicting the Unseen.
Protecting Your Future.

The world's first AI-driven wearable using FDA-recognized patterns to detect cardiovascular events before they happen.

See The Tech Investor Info

SCROLL

The Global Challenge

Cardiovascular disease is the #1 cause of death globally.

17.9M

Global Deaths Annually

Responsible for 32% of all global mortality.

85%

Preventable Events

Most deaths are due to heart attacks and strokes.

$239B

Healthcare Burden

The estimated annual economic cost in the U.S.

Proprietary Technology

ECN-DM & Microalternance

Beyond standard ECG. We analyze minute electrical variations traditional machines ignore.

Rolling Window Analysis

Seeing the Unseen

Unlike traditional algorithms that compare your heart to a population average, AI Heart analyzes your unique signature.

Our system evaluates successive 2-, 3-, and 4-beat segments within a rolling 30-beat window. This allows us to detect electrical instability and ischemia minutes or hours before a cardiac event.

30-Beat Window

Athletic Performance

Red Zone vs. Green Zone

Optimize training and prevent injury. Our technology visualizes your heart's oxygenation state in real-time.

  • ● Green Zone: Heart is oxygenated. Ideal for endurance.
  • ● Red Zone: Hypoxia detected. Rest required to prevent cardiac strain.

Gold Standard Comparison

Diagnostic Method Sensitivity Specificity Scan Time Cost (Est)
AI Heart (ECN-DM) 95% 88% 3 Min $50
Standard ECG 34% 51% 5 Min $200
Cardiac Echo 60% 74% 60 Min $2,500
MRI 87% 82% 60 Min $2,900

Meet the Visionaries

Leaders in Medicine, Law, Technology, and Business.

Board of Directors

CEO & Director

Peter Moeller

Chief Growth Officer for Scarinici and Hollenbeck Law Firm. Winner of Marcum Award for Best of Best 40 and Under 40 Marketing award.

President & Director

Dr. Mary Jo Sullivan

RN, MN, DN. Past Director of Nursing for Kaiser Piedmont Northern California overseeing 21 Hospitals and 2,000 nurses. 48 years medical experience.

Chairman

Robert Carella

Co-Founder and CFO of Ledger Artificial Intelligence. Adjunct Professor of Advanced Crypto Technology. Member of Boca Raton Chamber of Commerce.

Secretary & Treasurer

Gerard Ascolese

Owner of ASAP Media. 40+ years in media production. Producer of 152 Episodes of Slicing Jersey, featured on ESPN, Fox, ABC, NBC, CBS and CNN.

Executive VP & Director

Nancy Messina

Account Executive for 20 years at Spin Master. Sales Associate at GUND Partnership. Vast experience in client engagement.

Advisory Board

Chief Cardiologist Advisor

Dr. James A. Sbarbaro

M.D., F.A.C.C. Renowned Cardiologist with 45 years experience. Scientific Postgraduate activities with American Heart Association.

Medical Advisor

Deborah Sbarbaro

RN Cardiopulmonary Rehab. 32 years of nursing experience. Extensive neurologic and cardiopulmonary care expertise.

Nutrition Advisor

Dr. Sandra Frank

Registered Dietitian Nutritionist. Ranked #5 top wellness dietician in USA by Global Data. Expert in sustainable nutrition.

Blockchain Strategist

Andre Kennedy

Founder of Arksphere. Early investor in Helium Mobile. 5+ years experience designing and integrating blockchain strategies.

Investment Opportunity

Secure early equity in the future of AI-driven cardiovascular health.

Shares Offered

41,000,000 Common Shares

Price Per Share

$0.0001

Offering Type

Rule 506(c) Regulation D

Eligibility

Accredited Investors Only

Use of Proceeds

Funds will be deployed to initiate planned day-to-day business operations, including technology development, watch and ring manufacturing sourcing, and compliance fees.

Key Risk Factors

Investment in AI Heart Inc. involves a high degree of risk. Prospective investors should carefully consider the following:

  • Limited Operating History: The Company was formed in Nov 2025 and has no history of revenues.
  • Arbitrary Offering Price: The price of $0.0001 was arbitrarily determined by management and does not reflect book value or assets.
  • Best Efforts Offering: There is no minimum offering amount. The company may close on any amount raised, which may be insufficient for operations.
  • Transfer Restrictions: Shares are "Restricted Securities" under Rule 144 and cannot be easily resold.

Join the Revolution

Sign up for Early Access or request Investor Information.